Associated Papers
Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients.
Hou X et al.
Journal of Molecular Medicine (berlin, Germany), 2014
OPN gene polymorphisms influence the risk of knee OA and OPN levels in synovial fluid in a Chinese population.
Jiang Y et al.
Arthritis Research & Therapy, 2013
The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2010
SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum.
Hendig D et al.
Clinical Chemistry, 2007
A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression.
Hummelshoj T et al.
Molecular Immunology, 2006
Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F et al.
Physiological Genomics, 2004
Select a paper to view details